ERF — Eurofins Scientific SE Cashflow Statement
0.000.00%
Last trade - 00:00- €12.18bn
- €15.85bn
- €7.30bn
- 73
- 31
- 76
- 66
Annual cashflow statement for Eurofins Scientific SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,057 | 780 | 423 | 555 | 654 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 227 | 12.2 | 135 | 189 | 254 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -315 | -265 | -204 | -117 | -138 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,512 | 1,136 | 1,018 | 1,319 | 1,400 |
| Capital Expenditures | -506 | -660 | -550 | -528 | -537 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -515 | -196 | -131 | -318 | -539 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,021 | -856 | -681 | -847 | -1,076 |
| Financing Cash Flow Items | -206 | -503 | -308 | -168 | -565 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -910 | -311 | 414 | -1,090 | -102 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -396 | -31.8 | 738 | -608 | 175 |